Patient perceived attitudes and practice patterns regarding hormone replacement therapy (HRT) after risk reducing gynecologic surgery for Lynch syndrome

被引：0
|
作者：
Hodeib, M. [1 ]
Cheng, C. [2 ]
Holschneider, C. H. [3 ]
Dhaliwal, J. K. [4 ]
Pineda, E. [4 ]
Sinno, A. K. [3 ]
机构：
[1] Cedars Sinai Med Ctr, Womens Canc Program, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA
来源：
GYNECOLOGIC ONCOLOGY | 2018年 / 149卷
关键词：
D O I：
10.1016/j.ygyno.2018.04.461
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
451
引用
收藏
页码：203 / 203
页数：1
相关论文
共 24 条
  • [21] Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits
    Gordhandas, Sushmita
    Norquist, Barbara M.
    Pennington, Kathryn P.
    Yung, Rachel L.
    Laya, Mary B.
    Swisher, Elizabeth M.
    GYNECOLOGIC ONCOLOGY, 2019, 153 (01) : 192 - 200
  • [22] Withholding of Hormone Replacement Therapy Prior to Total Joint Arthroplasty Surgery to Reduce the Risk of Postoperative Thromboembolic Events: Is It Justified?dA Systematic Review of Clinical Practice Guidelines
    Abouharb, Alexander L. Z.
    Mehta, Sachit
    Rathnayake, Hasithe
    Pandit, Hemant
    JOURNAL OF ARTHROPLASTY, 2024, 39 (02): : 541 - 548.e24
  • [23] Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer?
    Domchek, S. M.
    Friebel, T.
    Neuhausen, S. L.
    Lynch, H. T.
    Singer, C. F.
    Eeles, R. A.
    Isaacs, C.
    Tung, N. M.
    Ganz, P. A.
    Couch, F. J.
    Weitzel, J. N.
    Olopade, O. I.
    Rubinstein, W. S.
    Tomlinson, G. E.
    Pichert, G. C.
    Daly, M. B.
    Matloff, E. T.
    Evans, D. G.
    Garber, J. E.
    Rebbeck, T. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis
    Marchetti, C.
    De Felice, F.
    Boccia, S.
    Sassu, C.
    Di Donato, V.
    Perniola, G.
    Palaia, I.
    Monti, M.
    Muzii, L.
    Tombolini, V.
    Panici, P. Benedetti
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 132 : 111 - 115
123